CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
29 hedge funds and large institutions have $114M invested in Crescent Biopharma, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $9K | 1,081 | +1,081 | New |
|
|
TCOV
27
Trust Company of Vermont
Brattleboro,
Vermont
| $1K | 110 | – | – |
|
|
GC
28
Globeflex Capital
San Diego,
California
| $1K | 83 | +83 | New |
|
|
MSA
29
Mason Street Advisors
Milwaukee,
Wisconsin
| – | – | -101,985 | Closed |
|
30
T. Rowe Price Associates
Baltimore,
Maryland
| – | – | -91,324 | Closed |
|
31
Blackstone Inc
New York
| – | – | -16,576 | Closed |
|
|
PC
32
Polar Capital
London,
United Kingdom
| – | – | -15,994 | Closed |
|
33
Bank of America
Charlotte,
North Carolina
| – | – | -5,967 | Closed |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -74 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| $0 | 1 | – | – |
|